HEALTH Covid-19:West Bengal Government expedites vaccine campaign, asks for more doses West Bengal government plans to step up its vaccination campaign in the state since Covid-19 instances in China and several other nations have increased. More than 15 lakh doses have been requested by the state from the Center.
HEALTH Covid-19: Intranasal Covid vaccine from Bharat Biotech to cost Rs 325 in government hospitals and Rs 800 in private Covid-19: The intranasal Covid vaccine iNCOVACC from Bharat Biotech will go on sale in the fourth week of January.
HEALTH DCGI approves Covaxin for emergency use for kids DGCI gave Bharat Biotech approval for emergency use authorisation of the Covaxin COVID-19 vaccine for children in the 12-18 years age group.
HEALTH Bharat Biotech's COVID-19 vaccine is 50% effective: study Two doses of Bharat Biotech's COVID-19 vaccine 'Covaxin' are 50 per cent effective against symptomatic disease.
POLITICS Covaxin 77.8% effective against Covid-19 in Lancet study Covaxin, a vaccine developed by government's medical research agency and Bharat Biotech International Ltd., was found to have a 77.8% efficacy.
WORLD UK To Recognise Covaxin from November 22 According to a statement by the UK government, Covaxin will be approved for international travellers from November 22.
/dnp-english/media/agency_attachments/2024/11/25/2024-11-25t064936166z-dnp-india-logo-640x480-dnp-news-2.png){kind=logo}